Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New program helps kids with type 1 diabetes take control

NCT ID NCT04336969

First seen Mar 05, 2026 · Last updated Jun 23, 2026 · Updated 21 times

Summary

This study tested a program called 4T (Teamwork, Targets, Technology, Tight Control) for children and teens newly diagnosed with type 1 diabetes. The program uses continuous glucose monitor data to give personalized feedback to families. Researchers measured changes in blood sugar levels and how patients felt about using the device. The goal was to improve diabetes management and patient well-being.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE1DIABETES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Franziska Katherine Bishop

    Steamboat Springs, Colorado, 80487, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

4T Education and Care (behavioral intervention using CGM feedback)

What this could lead to

If successful, this program could help children with new-onset type 1 diabetes better manage their blood sugar and improve their quality of life.

What could go wrong

This is a completed study, so results are already known. The intervention is behavioral, so benefits may vary by family and may not apply to all populations.

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.